Journal of HIV & Retro Virus Open Access

  • ISSN: 2471-9676
  • Journal h-index: 8
  • Journal CiteScore: 0.92
  • Journal Impact Factor: 1.50
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Articles published in Journal of HIV & Retro Virus have been cited by esteemed scholars and scientists all around the world. Journal of HIV & Retro Virus has got h-index 8, which means every article in Journal of HIV & Retro Virus has got 8 average citations.

Following are the list of articles that have cited the articles published in Journal of HIV & Retro Virus.

  2021 2020 2019 2018 2017

Year wise published articles

13 64 22 18 5

Year wise citations received

13 64 22 18 32
Journal total citations count 191
Journal impact factor 1.50
Journal 5 years impact factor 0.89
Journal cite score 0.92
Journal h-index 8
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
A high-throughput and multiplex microsphere immunoassay based on non-structural protein 1 can discriminate three flavivirus infections
Investigating the Testicular Tropism of Zika Virus Using 2D and 3D Human Tissue Culture Systems
Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA
A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests
Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections
Serological Diagnosis of Flavivirus-Associated Human Infections
Evaluation of 5 Commercially Available Zika Virus Immunoassays
Drug delivery via tattooing: Effect of needle and fluid properties
Investigation of cell death caused by the Nanopatch™ and its role in vaccine delivery as a physical immune enhancer
Insights into the application of chitosan as an anti-leishmanial compound.
Modern Drug Discovery and Development in the Area of Leishmaniasis
Amphotericin-B-loaded polymer-functionalized reduced graphene oxides for Leishmania amazonensis chemo-photothermal therapy
Host and parasite factors that regulate secondary immunity to experimental cutaneous leishmaniasis
Computer-Assisted Design of Thiophene-Indole Hybrids as Leishmanial Agents
Transcription Factor Target Gene Network governs the Logical Abstraction Analysis of the Synthetic Circuit in Leishmaniasis
Leishmaniasis - Drugs, Nanotechnology Based Delivery Systems and Recent Patents Survey
Estudio de la infección por Leishmania infantum en el perro: utilidad de las técnicas diagnósticas no invasivas y nuevas alternativas terapéuticas
Use of dermograph for improvement of PpIX precursor’s delivery in photodynamic therapy: Experimental and clinical pilot studies
Pharmacokinetics and pharmacodynamics of oleylphosphocholine in a hamster model of visceral leishmaniasis
Hairless mice as an experimental model of infection with Leishmania (Leishmania) amazonensis